← The Wire
VALNNasdaq
Valneva SE
Biological Products, (No Diagnostic Substances) · I0 · CIK 1836564
Valneva develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs
$508M
Market cap
$5.17
Last close
-0.4%
1D
-3.4%
5D
37K
Volume
Price · last 39 sessions+0.0%
May 4L $5.17 · H $6.34Jun 29
208
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
6-K6-KJun 25, 20266-K6-KJun 5, 20266-K6-KJun 1, 20266-K6-KMay 13, 2026SC 13D/ASC 13D/AMay 12, 20266-K6-KMay 5, 20266-K6-KApr 30, 20266-K6-KMar 26, 20266-K6-KMar 23, 20266-K6-KMar 18, 202620-F20-FMar 17, 2026SC 13D/ASC 13D/AMar 10, 20266-K6-KMar 9, 20266-K6-KMar 2, 20266-K6-KFeb 19, 20266-K6-KFeb 13, 20266-K6-KFeb 3, 20266-K6-KJan 20, 20266-K6-KJan 9, 20266-K6-KDec 31, 20256-K6-KDec 11, 20256-K6-KNov 28, 20256-K6-KNov 26, 20256-K6-KNov 20, 20256-K6-KNov 4, 20256-K6-KOct 6, 20256-K6-KOct 6, 20256-K6-KSep 3, 20256-K6-KAug 25, 20256-K6-KAug 18, 20256-K6-KAug 12, 20256-K6-KAug 7, 20256-K6-KJul 11, 20256-K6-KJun 26, 20256-K6-KJun 25, 20256-K6-KJun 5, 20256-K6-KJun 4, 20256-K6-KMay 27, 20256-K6-KMay 12, 20256-K6-KMay 7, 20256-K6-KApr 28, 20256-K6-KApr 18, 20256-K6-KApr 16, 20256-K6-KApr 14, 20256-K6-KApr 9, 20256-K6-KApr 1, 20256-K6-KMar 31, 20256-K6-KMar 25, 202520-F20-FMar 24, 20256-K6-KMar 24, 20256-K6-KMar 20, 20256-K6-KMar 3, 20256-K6-KFeb 28, 20256-K6-KFeb 18, 20256-K6-KFeb 5, 20256-K6-KJan 30, 20256-K6-KJan 23, 20256-KCOVERJan 21, 20256-K6-KJan 7, 20256-KFORM 6-KDec 19, 20246-KFORM 6-KDec 4, 20246-KFORM 6-KDec 3, 20246-KFORM 6-KNov 26, 20246-KFORM 6-KNov 13, 20246-K6-KNov 7, 20246-KFORM 6-KOct 21, 20246-KFORM 6-KOct 16, 20246-KFORM 6-KOct 10, 20246-KFORM 6-KOct 3, 20246-KFORM 6-KSep 18, 20246-K6-KSep 13, 20246-KFORM 6-KSep 3, 20246-K6-KAug 13, 20246-KFORM 6-KAug 1, 20246-KFORM 6-KJul 22, 20246-KFORM 6-KJul 18, 20246-KFORM 6-KJul 1, 20246-KFORM 6-KJun 27, 20246-KFORM 6-KJun 24, 20246-KFORM 6-KJun 5, 2024
Similar companies
Comparable business profile · signals at a glance